February 10, 2022 -- BioAuxilium Research is expanding its no-wash Thunder time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio by introducing new cell-signaling pathway and biomarker research assay kits, along with a panel of mix-and-match toolbox reagents. The new offering brings the company's portfolio to a total of 104 products.
Developed and manufactured at BioAuxilium's laboratories, the new Thunder TR-FRET assay kits are ideal for studying intra or extracellular signaling pathways and include key human kinases, proinflammatory cytokines, and a cyclic adenosine monophosphate detection kit designed for screening and characterizing G protein-coupled receptors.
The Thunder TR-FRET toolbox reagents include europium and far-red labeled antispecies, antiepitope, and streptavidin for enabling easy in-house assay development. All Thunder TR-FRET products are extensively validated to ensure specificity, sensitivity, and reproducibility using real-life biological samples, according to the company.
BioAuxilium is a private Canadian biotechnology tool company founded by assay scientists.